Showing 18,281 - 18,300 results of 46,288 for search '(( 50 ((we decrease) OR (a decrease)) ) OR ( 5 ((step decrease) OR (mean decrease)) ))', query time: 1.61s Refine Results
  1. 18281

    Table_2_Impacts of smoking on alcoholic liver disease: a nationwide cohort study.docx by Jeong-Ju Yoo (3666826)

    Published 2024
    “…Objectives<p>Smoking is a preventable risk factor for morbidity and mortality in patients with liver disease. …”
  2. 18282

    Table_1_Impacts of smoking on alcoholic liver disease: a nationwide cohort study.docx by Jeong-Ju Yoo (3666826)

    Published 2024
    “…Objectives<p>Smoking is a preventable risk factor for morbidity and mortality in patients with liver disease. …”
  3. 18283

    Image_2_Impacts of smoking on alcoholic liver disease: a nationwide cohort study.pdf by Jeong-Ju Yoo (3666826)

    Published 2024
    “…Objectives<p>Smoking is a preventable risk factor for morbidity and mortality in patients with liver disease. …”
  4. 18284

    Table_3_Impacts of smoking on alcoholic liver disease: a nationwide cohort study.docx by Jeong-Ju Yoo (3666826)

    Published 2024
    “…Objectives<p>Smoking is a preventable risk factor for morbidity and mortality in patients with liver disease. …”
  5. 18285

    Apoptosis inhibition by <i>Simkania</i> is a function of time and infection dose and is independent of the stimulus. by Karthika Karunakaran (212688)

    Published 2011
    “…<p>(<b>A</b>) Immunofluorescence analysis of the time and dose dependency of <i>Simkania</i> mediated anti-apoptosis. …”
  6. 18286

    Image_1_Impacts of smoking on alcoholic liver disease: a nationwide cohort study.pdf by Jeong-Ju Yoo (3666826)

    Published 2024
    “…Objectives<p>Smoking is a preventable risk factor for morbidity and mortality in patients with liver disease. …”
  7. 18287

    Table_5_Impacts of smoking on alcoholic liver disease: a nationwide cohort study.docx by Jeong-Ju Yoo (3666826)

    Published 2024
    “…Objectives<p>Smoking is a preventable risk factor for morbidity and mortality in patients with liver disease. …”
  8. 18288
  9. 18289
  10. 18290
  11. 18291
  12. 18292
  13. 18293
  14. 18294
  15. 18295
  16. 18296
  17. 18297

    Effect of plasmid DNA methylation on <i>PPP2R1A</i> promoter activity. by Hui-Feng Chen (325652)

    Published 2013
    “…</b> The CpG islands of the 5′-flanking region of <i>PPP2R1A</i>. The region from −400 nt to +105 nt was identified as a CpG island using the CpG finder at EMBL (<a href="http://www.ebi.ac.uk/" target="_blank">http://www.ebi.ac.uk/</a>) and the following parameters: CpG length >200 bp, G+C >50% and a “CpG value” of at least 0.6. …”
  18. 18298

    CRISPRi knockdowns of candidate genes and phenotypic characterization of GBS lacking MrvR in amniotic fluid, rich media, and biofilm-promoting growth conditions. by Allison N. Dammann (10271174)

    Published 2021
    “…A qPCR-based multiplex CRISPRi screen using knockdowns of all five candidate genes revealed decreased fitness in amniotic fluid compared to tryptic soy (TS) broth (<b>C</b>); black columns show the competition index of strains bearing individual targeting protospacer plasmids, while red columns show pooled results from both targeting plasmids for each gene. …”
  19. 18299
  20. 18300